BioMark has recently completed a very encouraging metabolome study that has implication for biomarker signature related to cancer diagnosis. The discovery is being patented.
No paperwork, no hassle. We keep things digital, easy and regular.
*Zero Spam Policy. You will need to confirm your email address to receive our news to your inbox.
BioMark Diagnostics Highlights Fiscal Year 2025 Achievements and Sets Bold Strategic Milestones for 2025 –
Form 7 Monthly Progress Report June 2025 Name of Listed Issuer: Trading Symbol: Number of
Novel Graph Neural Network (N-GNN) Model Achieves Superior Accuracy in Early Lung Cancer Detection, Paving
Form 7 Monthly Progress Report May 2025 Name of Listed Issuer: Trading Symbol: Number of
Study Published in a special issue of International Journal of Molecular Sciences Confirms Test’s Ability
1 604 370 0779
130 3851 Shell Road
Richmond BC
Canada V6X 2W2